Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung-Fu Tseng

Showing results (101-110 of 148) with videos related to

Pageof 15
Sort By:
Vaccine|October 26, 2019
Safety of quadrivalent meningococcal conjugate vaccine in infants and toddlers 2 to 23-months oldTracy A Becerra-Culqui, Lina S Sy, Bradley K Ackerson, et al.
Vaccine|April 13, 2013
Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in childrenHung Fu Tseng, Lina S Sy, In-Lu Amy Liu, et al.
Vaccine|November 10, 2015
Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008-2011Allison L Naleway, Brad Crane, Ning Smith, et al.
Vaccine|July 1, 2018
Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitusRulin C Hechter, Lei Qian, Yi Luo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2024
Comparative Effectiveness of Licensed Influenza Vaccines in Preventing Influenza-related Medical Encounters and Hospitalizations in the 2022-2023 Influenza Season Among Adults ≥65 Years of AgeJennifer H Ku, Emily Rayens, Lina S Sy, et al.
Influenza and Other Respiratory Viruses|December 19, 2024
Comparative Effectiveness of Cell-Based Versus Egg-Based Influenza Vaccines in Prevention of Influenza Hospitalization During the 2022-2023 Season Among Adults 18-64 YearsEmily Rayens, Jennifer H Ku, Lina S Sy, et al.
Environmental Health Perspectives|February 23, 2023
Impact of a Statewide Livestock Antibiotic Use Policy on Resistance in Human Urine <i>Escherichia coli</i> Isolates: A Synthetic Control AnalysisJoan A Casey, Sara Y Tartof, Meghan F Davis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2022
Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent AdultsAna Florea, Lina S Sy, Lei Qian, et al.
Vaccine|May 12, 2023
Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort studyJennifer H Ku, Lina S Sy, Lei Qian, et al.
The Pediatric Infectious Disease Journal|July 19, 2017
Safety of Quadrivalent Meningococcal Conjugate Vaccine in Children 2-10 YearsSara Yee Tartof, Lina S Sy, Bradley K Ackerson, et al.
Pageof 15

Showing results (101-110 of 148) with videos related to

Sort By:
Pageof 15
Vaccine|October 26, 2019
Safety of quadrivalent meningococcal conjugate vaccine in infants and toddlers 2 to 23-months oldTracy A Becerra-Culqui, Lina S Sy, Bradley K Ackerson, et al.
Vaccine|April 13, 2013
Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in childrenHung Fu Tseng, Lina S Sy, In-Lu Amy Liu, et al.
Vaccine|November 10, 2015
Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008-2011Allison L Naleway, Brad Crane, Ning Smith, et al.
Vaccine|July 1, 2018
Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitusRulin C Hechter, Lei Qian, Yi Luo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2024
Comparative Effectiveness of Licensed Influenza Vaccines in Preventing Influenza-related Medical Encounters and Hospitalizations in the 2022-2023 Influenza Season Among Adults ≥65 Years of AgeJennifer H Ku, Emily Rayens, Lina S Sy, et al.
Influenza and Other Respiratory Viruses|December 19, 2024
Comparative Effectiveness of Cell-Based Versus Egg-Based Influenza Vaccines in Prevention of Influenza Hospitalization During the 2022-2023 Season Among Adults 18-64 YearsEmily Rayens, Jennifer H Ku, Lina S Sy, et al.
Environmental Health Perspectives|February 23, 2023
Impact of a Statewide Livestock Antibiotic Use Policy on Resistance in Human Urine <i>Escherichia coli</i> Isolates: A Synthetic Control AnalysisJoan A Casey, Sara Y Tartof, Meghan F Davis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2022
Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent AdultsAna Florea, Lina S Sy, Lei Qian, et al.
Vaccine|May 12, 2023
Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort studyJennifer H Ku, Lina S Sy, Lei Qian, et al.
The Pediatric Infectious Disease Journal|July 19, 2017
Safety of Quadrivalent Meningococcal Conjugate Vaccine in Children 2-10 YearsSara Yee Tartof, Lina S Sy, Bradley K Ackerson, et al.
Pageof 15